Literature DB >> 16268375

Ferritin levels in the cerebrospinal fluid and restless legs syndrome: effects of different clinical phenotypes.

Christopher J Earley1, James R Connor, John L Beard, Stacey L Clardy, Richard P Allen.   

Abstract

STUDY
OBJECTIVE: To determine whether patients with restless legs syndrome (RLS) and controls differ in regard to levels of ferritin and transferrin in the cerebrospinal fluid (CSF) when samples are collected at night, to determine whether patients with early-onset and late-onset RLS show a different outcome for CSF values, and to determine whether the CSF ferritin level correlates with disease severity.
DESIGN: Collection of CSF and plasma; assessment of disease severity using objective (periodic limb movements) and subjective (Johns Hopkins Restless Legs Severity Scale) measures of severity.
SETTING: General Clinical Research Center. PARTICIPANTS: Thirty subjects with idiopathic RLS (15 early- and 15 late-onset RLS) and 22 age- and sex-matched controls. INTERVENTION: N/A.
RESULTS: Nighttime CSF ferritin levels were lower in the total RLS group compared with controls. Further assessment found that the early-onset (less than 45 years of age) but not the late-onset (greater than or equal to 45 years of age) RLS group had significantly lower CSF ferritin levels compared with controls. There was a strong correlation between the age of symptom onset and CSF ferritin values (r = 0.64): the earlier the age, the lower the ferritin level. A regression analysis showed that both sex and RLS subtype had significant effects on the CSF ferritin level, with women with early-onset RLS having substantial lower values than men with late-onset RLS. A comparison between these nighttime CSF values and previously published daytime samples suggests that diurnal changes may have effects on the findings.
CONCLUSIONS: This study is distinct in showing that the degree of the CSF-ferritin effect is best defined by the clinical phenotypes of sex and age of symptom onset and by the time of day that samples are collected.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16268375     DOI: 10.1093/sleep/28.9.1069

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  23 in total

1.  Restless legs syndrome: diagnostic assessment and the advantages and risks of dopaminergic treatment.

Authors:  Birgit Högl; Walter Paulus; Peter Clarenbach; Claudia Trenkwalder
Journal:  J Neurol       Date:  2006-08       Impact factor: 4.849

2.  Recent advances in the diagnosis, genetics and treatment of restless legs syndrome.

Authors:  Claudia Trenkwalder; Birgit Högl; Juliane Winkelmann
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

Review 3.  Pathophysiology of restless legs syndrome: evidence for iron involvement.

Authors:  James R Connor
Journal:  Curr Neurol Neurosci Rep       Date:  2008-03       Impact factor: 5.081

4.  Diurnal variations in brain iron concentrations in BXD RI mice.

Authors:  E L Unger; B C Jones; L E Bianco; R P Allen; C J Earley
Journal:  Neuroscience       Date:  2014-01-07       Impact factor: 3.590

5.  Periodic Leg Movements in Sleep and Restless Legs Syndrome: Considerations in Geriatrics.

Authors:  Donald L Bliwise
Journal:  Sleep Med Clin       Date:  2006-06-01

6.  Extracellular vesicles reveal abnormalities in neuronal iron metabolism in restless legs syndrome.

Authors:  Sahil Chawla; Seema Gulyani; Richard P Allen; Christopher J Earley; Xu Li; Peter Van Zijl; Dimitrios Kapogiannis
Journal:  Sleep       Date:  2019-07-08       Impact factor: 5.849

7.  Pharmacological Management of Restless Legs Syndrome and Periodic Limb Movement Disorder in Children.

Authors:  Geoffrey Rulong; Thomas Dye; Narong Simakajornboon
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

8.  Iron-deficiency and dopaminergic treatment effects on RLS-Like behaviors of an animal model with the brain iron deficiency pattern of the restless legs syndrome.

Authors:  Richard P Allen; Christopher J Earley; Byron C Jones; Erica L Unger
Journal:  Sleep Med       Date:  2020-02-05       Impact factor: 3.492

9.  Diurnal cycle influences peripheral and brain iron levels in mice.

Authors:  Erica L Unger; Christopher J Earley; John L Beard
Journal:  J Appl Physiol (1985)       Date:  2008-11-06

10.  Loss of NCB5OR in the cerebellum disturbs iron pathways, potentiates behavioral abnormalities, and exacerbates harmaline-induced tremor in mice.

Authors:  Matthew A Stroh; Michelle K Winter; Russell H Swerdlow; Kenneth E McCarson; Hao Zhu
Journal:  Metab Brain Dis       Date:  2016-05-18       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.